Heraeus Kulzer, GmbH v. Biomet, Inc., et al.

In the 2018 appeal of Heraeus Kulzer, GmbH v. Biomet, Inc.,
Heraeus, a German company specializing in bone cements,
accused Biomet of misappropriating its trade secrets to develop
competing products. This case, filed under 28 U.S.C. § 1782 in
the Northern District of Indiana, sought discovery for use in a
foreign proceeding in Germany, where Heraeus had already
obtained a favorable judgment. The crux of the matter revolved
around the alleged trade secret misappropriation by Biomet
with the assistance of Esschem, Inc. Despite dominating the
bone cement market for decades, Heraeus claimed it lost
market share due to this misappropriation. The district court’s
denial to modify protective orders to further protect Heraeus’s
trade secrets and enforce the German judgment in Europe was
appealed. The Seventh Circuit found it lacked jurisdiction over
the initial orders due to untimely appeals but affirmed the
district court’s discretion in the final order, highlighting the
challenges of cross-border trade secret litigation and the
strategic use of § 1782 actions.